Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
88.25%
-
Total 13F principal
-
$413,202,564
-
Principal change
-
-$39,854,582
-
Total reported market value
-
$363,891,303
-
Number of holders
-
58
-
Value change
-
-$36,272,462
-
Number of buys
-
24
-
Number of sells
-
21
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q4 2017
As of 31 Dec 2017,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
58 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$413,202,564
in principal (par value) of the bond.
The largest 10 bondholders included
PRUDENTIAL PLC, Allianz Asset Management GmbH, AXA, INCOME RESEARCH & MANAGEMENT, WELLS FARGO & COMPANY/MN, RIVERHEAD CAPITAL MANAGEMENT LLC, Southpaw Asset Management LP, ARISTEIA CAPITAL LLC, PICTET ASSET MANAGEMENT LTD, and Invesco Ltd..
This page lists
58
institutional bondholders reporting positions
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.